22,741 Shares in Oscar Health, Inc. (NYSE:OSCR) Purchased by Centiva Capital LP

Centiva Capital LP purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 22,741 shares of the company's stock, valued at approximately $306,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of Oscar Health by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock worth $255,333,000 after purchasing an additional 586,626 shares during the period. JPMorgan Chase & Co. increased its holdings in Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after purchasing an additional 8,051,379 shares during the period. Gilder Gagnon Howe & Co. LLC raised its position in Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after purchasing an additional 2,151,256 shares during the last quarter. BIT Capital GmbH lifted its holdings in Oscar Health by 5,711.6% in the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock worth $60,129,000 after buying an additional 4,396,872 shares during the period. Finally, Geode Capital Management LLC grew its position in shares of Oscar Health by 3.0% in the 4th quarter. Geode Capital Management LLC now owns 4,468,098 shares of the company's stock worth $60,065,000 after buying an additional 128,458 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Insider Activity at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the transaction, the director now owns 64,512 shares of the company's stock, valued at $1,059,932.16. This trade represents a 27.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 24.39% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their target price for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, two have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $20.08.

Oscar Health Stock Up 5.8%

Shares of NYSE:OSCR traded up $0.96 during trading on Friday, hitting $17.52. The stock had a trading volume of 10,504,285 shares, compared to its average volume of 4,180,130. The company has a market capitalization of $4.39 billion, a PE ratio of -875.31 and a beta of 1.75. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm's fifty day moving average is $13.40 and its 200 day moving average is $14.65. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.83 by $0.09. The business had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company's revenue for the quarter was up 42.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.62 earnings per share. Analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.